In breast cancer with high CD44 expression, TAMs release CCL8 to activate MDM2-p53 signaling and promote CD44 expression, thereby inducing tumor cell detachment, which facilitates breast cancer invasion and metastasis. This evidence concerns the gene CCL8 and breast carcinoma.